Kinetin riboside preferentially induces apoptosis by modulating Bcl-2 family proteins and caspase-3 in cancer cells.
Bo-Hwa Choi, Wanil Kim, Qiuxia Chelsia Wang, Dong-Chan Kim, Swee Ngin Tan, Jean Wan Hong Yong, Kyong-Tai Kim, Ho Sup Yoon
Index: Cancer Lett. 261 , 37-45, (2008)
Full Text: HTML
Abstract
Here, we demonstrate that kinetin riboside (KR), a cytokinin analog, induces apoptosis in HeLa and mouse melanoma B16F-10 cells. KR disrupted the mitochondrial membrane potential and induced the release of cytochrome c and activation of caspase-3. Bad were upregulated while Bcl-2 was down-regulated under KR exposure. A tumor growth in mice was dramatically suppressed by KR. In contrast, human skin fibroblast CCL-116 and bovine primary fibroblast cells show resistances to KR and no significant changes in Bad, Bcl-X(L,) and cleaved PARP were observed. Our data suggest that KR selectively induces apoptosis in cancer cells through the classical mitochondria dependent apoptosis pathway.
Related Compounds
Related Articles:
2015-08-01
[Anal. Bioanal. Chem 407 , 6071-9, (2015)]
2008-04-01
[Bioorg. Med. Chem. 16 , 3848-65, (2008)]
2008-07-24
[J. Med. Chem. 51 , 4260-9, (2008)]
2008-05-01
[J. Clin. Invest. 118 , 1750-1764, (2008)]
2002-01-01
[Cell Growth Differ. 13 , 19-26, (2002)]